Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study

Taken together, our data support the utility of drugs targeting the α7 nAChRs, perhaps especially α7 PAMs, to potentiate the effect of atypical antipsychotic drugs. Moreover, our data suggest that α7 agonists and PAMs can be used to ameliorate cognitive symptoms in schizophrenia and depression.

I wonder why no one is excited about the a7 nachrs meds when they will improve our lives significantly. Maybe its just a lack of education where nobody knows what they are. Ever since the disappointment with encenicline ive become impatient to have one of these drugs out. I want to be able to think clearly again.